VCEL
Vericel Corp
NASDAQ · Biotechnology
$36.19
+0.81 (+2.29%)
Open$35.69
Previous Close$35.38
Day High$36.54
Day Low$34.83
52W High$62.15
52W Low$29.24
Volume—
Avg Volume437.0K
Market Cap1.83B
P/E Ratio139.91
EPS$0.19
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+20.5% upside
Current
$36.19
$36.19
Target
$43.60
$43.60
$27.22
$43.60 avg
$49.94
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 232.15M | 201.96M | 161.47M |
| Net Income | 10.14M | 7.94M | 29.76M |
| Profit Margin | 4.4% | 4.2% | 18.4% |
| EBITDA | 10.00M | 8.26M | 51.23M |
| Free Cash Flow | — | — | 38.71M |
| Rev Growth | +15.0% | +15.0% | -9.0% |
| Debt/Equity | 0.00 | 0.00 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |